D&D Pharmatech Inc. (KOSDAQ:347850)

D&D Pharmatech Revenue

D&D Pharmatech had revenue of 1.41B KRW in the quarter ending March 31, 2025, a decrease of -32.76%. This brings the company's revenue in the last twelve months to 10.75B, down -32.15% year-over-year. In the year 2024, D&D Pharmatech had annual revenue of 11.44B, down -38.77%.

• Revenue (ttm): 10.75B
• Revenue Growth: -32.15%
• P/S Ratio: 132.29
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1,421.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.44B	-7.24B	-38.77%
Dec 31, 2023	18.68B	18.07B	2,958.97%
Dec 31, 2022	610.57M	-753.54M	-55.24%
Dec 31, 2021	1.36B	-	-
Dec 31, 2020	-	-	-